Clinical trial
TRANSFORM - Observational Cohort Study of Aranesp Use in EU Haemodialysis Patients Switched From Mircera
NCT01997892 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TRANSFORM - Observational Cohort Study of Aranesp Use in EU Haemodialysis Patients Switched From Mircera
- Lead sponsor
- Amgen
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- July 31, 2013
- Enrollment
- 1,027 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.